Arbutus Biopharma (NASDAQ:ABUS) Cut to “Sell” at StockNews.com
Arbutus Biopharma (NASDAQ:ABUS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Tuesday. Other equities research analysts have also issued reports about the stock. HC Wainwright reaffirmed a “buy” rating and set a $5.00 price objective on shares of […]
Arbutus Biopharma (NASDAQ:ABUS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Tuesday. Other equities research analysts have also issued reports about the stock. HC Wainwright reaffirmed a “buy” rating and set a $5.00 price objective on shares of […]
